Kirkland Advises CD&R on Potential Partnership with Sanofi to Acquire Opella

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

EUR 16bn (€16 billion)

What the figure measures

Enterprise value

Client

CD&RBuy-side

Counterparties

Sanofi (Sell-side)